Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
04 March 2022
Closing Date:
17 March 2022
Location(s):
PL POLSKA (PL Poland/POLSKA)
Description:
Delivery of Prevenar 13 or another equivalent single-dose vaccine against pneumococcal infection registered in Poland and approved for use in persons over 50 years of age...

The subject of the contract shall be the supply of Prevenar 13 vaccine or another equivalent single-dose vaccine against pneumococcal infection registered in Poland and approved for use in persons over 50 years of age for the Mazowiecki Bródnowski Hospital in Warsaw Sp. z o.o. within the framework of the ' Health Policy Programme for pneumococcal vaccination for persons over fifty years of age from Mazowieckie Voivodeship” for the years 2021 to 2023, MSB/PN/19/02/2022, the detailed scope and subject of which is specified in the assortment and price specification annexed No. 5 to SWZ.

Delivery of Prevenar 13 or another equivalent single-dose vaccine against pneumococcal infection registered in Poland and approved for use in persons over 50 years of age for Mazovian Bródnowski Hospital in Warsaw Sp. z o.o. under the “Health Policy Programme in the field of vaccination against pneumococcus for persons over fifty years of age from the Mazowieckie Voivodeship” for the years 2021 to 2023, MSB/PN/19/02/2022, whose detailed scope and subject matter is specified in the assortment and price specification annex 5 to SWZ.

Download full details as .pdf
The Buyer:
Mazowiecki Szpital Bródnowski w Warszawie Sp. z o.o.
CPV Code(s):
33600000 - Pharmaceutical products